title: The Hemobahn endoprosthesis: a self-expanding polytetrafluoroethylene-covered endoprosthesis for the treatment of peripheral arterial occlusive disease after balloon angioplasty.
abstract: Endoluminal management of occlusive arterial disease has previously been limited to balloon angioplasty, either alone or with stent placement. This article discusses the Hemobahn endoprosthesis, a polytetraflouroethylene-covered nitinol stent graft. The Hemobahn device design characteristics, Food and Drug Administration phase I feasibility trial design and results, phase II pivotal trial design, and single-site phase II trial results are reviewed. The long-term outcomes of patients treated with angioplasty and Hemobahn stent grafting will determine the role of stent grafting in the management of occlusive arterial lesions below the aortic bifurcation.
authors.affiliation: Sections of Vascular Surgery and Interventional Radiology, Washington University School of Medicine, USA.
authors.forename: B G
authors.initials: BG
authors.lastname: Rubin
authors.forename: G A
authors.initials: GA
authors.lastname: Sicard
mesh_terms: D000792:Angiography; D017130:Angioplasty / Q000295:instrumentation*; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000592:standards*; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D005240:Feasibility Studies; D006801:Humans; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D015607:Stents / Q000592:standards*; D016896:Treatment Outcome
chemical_list: D011138:Polytetrafluoroethylene